ArticleInfectious diseases and therapy2021

Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged ≥ 65 Years: Week 48 Results of a Phase 3b, Open-Label Trial.

Franco Maggiolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.